Preliminary Evaluation of Novel Triglyceride-Based Nanocomposites for Biomedical Applications

• Autor(a) principal: Almeida,Raimundo R. de
• Data de Publicação: 2017
• Outros Autores: Gallo,Juan, Silva,Aiêrta C. C. da, Silva,Ana K. O. da, Pessoa,Otilia D. L., Araújo,Tamara G., Leal,Luzia K. A. M., Fechine,Pierre B. A., Bañobre-López,Manuel, Ricardo,Nágila M. P. S.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Journal of the Brazilian Chemical Society (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532017000801547
• topic: lipid mixture; magnetic hyperthermia; drug delivery; oncocalyxone-A

This work describes the development and characterization of triglyceride-based magnetic nanocomposites for application in magnetic hyperthermia and controlled drug delivery. The magnetic solid lipid nanocomposites (MSLN) constituted by mixtures of trilaurin-tricaprylin and trilaurin-tricaprin have been successfully obtained by emulsification-solvent evaporation method. The developed MSLNs were subjected to an external oscillating magnetic field and showed significant hyperthermia. The samples were exposed to frequencies of 688 and 869 kHz causing, respectively, a temperature increase of 15.5 and 22.7 °C (trilaurin-tricaprylin) and 17.3 and 26.1 °C (trilaurin-tricaprin). Also, in vitro assays in the absence of magnetic field showed that the triglyceride-based formulations were able first to encapsulate and then to sustained release an antitumoural hydrophobic drug. After 72 h of assay trilaurin-tricaprylin and trilaurin-tricaprin released 73 and 55% of their cargo, respectively. In addition, MSLN exhibited low in vitro cytotoxic activity against human neutrophils.